Item 7 reads the 10-K, 10-Q and 8-K filings of the companies you follow and shows what changed since last quarter and last year, in plain English, next to the chart and the news. Every line links to its source.
Click a tab, or let it play. Everything here is an example with a fictional company.
For the rest of the year we expect revenue growth to continue at a similar rate expect revenue growth to moderate, reflecting lower orders from our largest customer and the timing of product launches.
Relies on a single contract manufacturer for its flagship product
10-Q ¶ 1A.7Report: Acme in talks with a second supplier
news wire · 06:40Material weakness in internal control, first disclosed this year
10-K ¶ 9A.2Analysts debate the margin outlook
news wire · yesterdayAcme Holdings · after the close · confirmed
Thu · company IR pageCPI release · 08:30 New York
Wed · BLS calendarFed statement · 14:00 New York
next Wed · Federal ReserveGlobex earnings · date not yet confirmed
estimateEach section is compared with last quarter's and last year's.
Every figure has to match the company's own reported numbers.
If a sentence can't be supported by its paragraph, you see the original text instead.
One click opens the exact text on sec.gov. Headlines are marked unverified unless a filing says the same.
Nothing is stated without the paragraph it came from.
News is marked unverified unless a filing says the same.
It explains what companies disclose. What you do with it is yours.
It never connects to your broker to place or manage orders.
People who invest their own money and want to understand the companies they own or follow, without reading hundreds of pages of legal text.
Companies that file reports with the U.S. Securities and Exchange Commission, which includes most U.S.-listed companies. You tell us which ones you follow.
From the companies' own filings on SEC EDGAR and the figures they report there. Every line links to the paragraph it came from, so you can always check it.
No. Item 7 explains what companies disclose. It doesn't recommend securities, predict prices or place trades, and it is not authorised or regulated by the Financial Conduct Authority.
Joining the waitlist is free. We'll share pricing with the first group before anyone is asked to pay.
Your own notes and journal, kept next to the evidence they refer to. Early members help decide what we build first.
We're opening to a small first group. Joining is free, and early members help shape what we build. One email when access opens, nothing else.